Wildy logo
(020) 7242 5778
enquiries@wildy.com

Wildy’s Book News

Book News cover photo

Vol 23 No 4 April/May 2018

Book of the Month

Cover of Williams, Mortimer and Sunnucks: Executors, Administrators and Probate

Williams, Mortimer and Sunnucks: Executors, Administrators and Probate

Edited by: Alexander Learmonth, Charlotte Ford, Julia Clark, John Ross Martyn
Price: £295.00

Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


Lowe legislation jp
Sealy millman 2018 jp
Court protection no 2
Desmith out now
Uk supremem 1 8
Williams published

Drug and Device Product Liability Litigation Strategy 2nd ed


ISBN13: 9780198803539
Previous Edition ISBN: 9780199734948
Published: January 2018
Publisher: Oxford University Press USA
Country of Publication: USA
Format: Hardback
Price: £200.00



Low stock.

Thousands of lawsuits continue to be filed in federal and state courts each year to seek recovery from manufacturers of pharmaceuticals and medical devices.

These lawsuits include individual actions, actions consolidated into federal multidistrict litigation, multi-plaintiff cases, and class actions. As drug and device litigation remains as active as ever, companies that develop new drugs and devices continue to face significant and often costly product liability litigation in the United States.

This new and revised edition of Drug and Device Product Liability Litigation Strategy provides detailed background, discussion, and strategic guidance to those practicing in this field. The book offers lawyers a detailed analysis of the full range of issues involved in drug and device litigation, including pre-litigation counselling, document preservation and discovery, consolidation and mass joinder, multidistrict litigation, class action litigation, admissibility of expert testimony, dispositive and pre-trial motion practice, jury selection, and trial.

This second edition not only contains thorough revisions to reflect recent changes in the legal landscape following key court decisions and statutory developments in areas such as preemption, admissibility of expert testimony, the learned intermediary doctrine, and innovator liability, but also contains new analyses of issues such as personal jurisdiction, pre-litigation counselling, and the amended Federal Rules of Civil Procedure. It is an indispensable guide to lawyers handling cases in this high-stake, high-profile, and rapidly evolving area.

Subjects:
Medical Law, Other Jurisdictions , USA
Contents:
1: Introduction
2: The FDA's Regulation of Prescription Drugs and Devices
3: Pre-litigation Counseling
4: Legal Issues & Theories
5: Consolidated Proceedings
6: Aggregated Proceedings - Class Actions
7: Aggregated Proceedings - Multidistrict Litigation
8: Fact Discovery
9: Expert Retention and Discovery
10: Expert Testimony, Rule 702, And Daubert
11: Preemption
12: The Learned Intermediary Doctrine
13: Motions In Limine
14: Jury Selection
15: The Trial Of A Drug Or Device Case
Index